US 12410418
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted A61PA61P31/20A61P7/04
Quick answer
US patent 12410418 (Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome) held by Precision BioSciences, Inc. expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Precision BioSciences, Inc.
- Grant date
- Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P31/20, A61P7/04